Yifei Lü

830 total citations
51 papers, 459 citations indexed

About

Yifei Lü is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yifei Lü has authored 51 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yifei Lü's work include Nutritional Studies and Diet (8 papers), Diet and metabolism studies (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Yifei Lü is often cited by papers focused on Nutritional Studies and Diet (8 papers), Diet and metabolism studies (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Yifei Lü collaborates with scholars based in United States, China and United Kingdom. Yifei Lü's co-authors include Guiju Sun, Dengfeng Xu, Shaokang Wang, Hui Xia, Chao Yang, Da Pan, Xian Yang, Gerardo Heiss, Hanzhang Xu and Jingkai Wei and has published in prestigious journals such as Circulation, Neurology and International Journal of Molecular Sciences.

In The Last Decade

Yifei Lü

43 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifei Lü United States 14 131 78 74 62 61 51 459
Jianrong Yao United States 14 91 0.7× 155 2.0× 85 1.1× 56 0.9× 32 0.5× 32 643
Bo Xie China 12 137 1.0× 100 1.3× 85 1.1× 83 1.3× 43 0.7× 28 685
Qingtao Hou China 9 77 0.6× 40 0.5× 41 0.6× 56 0.9× 53 0.9× 17 336
Deniz Suna Erdinçler Türkiye 14 182 1.4× 64 0.8× 67 0.9× 33 0.5× 28 0.5× 51 528
Şehkâr Oktay Türkiye 14 85 0.6× 133 1.7× 56 0.8× 59 1.0× 29 0.5× 62 510
Caterina Franco Italy 10 83 0.6× 69 0.9× 57 0.8× 42 0.7× 33 0.5× 26 371
Ana Cantón Spain 6 205 1.6× 124 1.6× 98 1.3× 47 0.8× 33 0.5× 8 578
Aurora E. Serralde‐Zúñiga Mexico 14 230 1.8× 61 0.8× 124 1.7× 83 1.3× 22 0.4× 61 540
Xinyu Shi China 14 54 0.4× 78 1.0× 39 0.5× 69 1.1× 57 0.9× 38 576
Iftikhar Alam Pakistan 17 256 2.0× 76 1.0× 62 0.8× 101 1.6× 29 0.5× 50 601

Countries citing papers authored by Yifei Lü

Since Specialization
Citations

This map shows the geographic impact of Yifei Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifei Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifei Lü more than expected).

Fields of papers citing papers by Yifei Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifei Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifei Lü. The network helps show where Yifei Lü may publish in the future.

Co-authorship network of co-authors of Yifei Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Yifei Lü. A scholar is included among the top collaborators of Yifei Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifei Lü. Yifei Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Canyu, et al.. (2025). Data-driven cluster analysis identifies three clinical phenotypes in hemodialysis patients. Renal Failure. 47(1). 2588961–2588961.
3.
Mok, Yejin, Yifei Lü, Shoshana H. Ballew, et al.. (2024). Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study. American Heart Journal. 274. 75–83. 1 indexed citations
4.
Liu, Yunhao, et al.. (2024). Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy. BMJ Open Respiratory Research. 11(1). e001702–e001702. 1 indexed citations
5.
Lü, Yifei, James Russell Pike, Ron C. Hoogeveen, et al.. (2024). Nonalcoholic Fatty Liver Disease and Longitudinal Change in Imaging and Plasma Biomarkers of Alzheimer Disease and Vascular Pathology. Neurology. 102(7). e209203–e209203. 11 indexed citations
8.
Lü, Yifei, James Russell Pike, Ron C. Hoogeveen, et al.. (2023). Liver integrity and the risk of Alzheimer's disease and related dementias. Alzheimer s & Dementia. 20(3). 1913–1922. 22 indexed citations
9.
Rothnie, Kieran, Yifei Lü, Raj Kumar Sharma, et al.. (2023). Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. International Journal of COPD. Volume 18. 2673–2685. 1 indexed citations
10.
Lü, Yifei, James Russell Pike, Anna Kucharska‐Newton, et al.. (2022). Aging-Related Multisystem Dysregulation Over the Adult Life Span and Physical Function in Later Life: The Atherosclerosis Risk in Communities (ARIC) Study. The Journals of Gerontology Series A. 78(8). 1497–1503.
11.
Xu, Dengfeng, Da Pan, YiFang Chu, et al.. (2022). Role of probiotics/synbiotic supplementation in glycemic control: A critical umbrella review of meta-analyses of randomized controlled trials. Critical Reviews in Food Science and Nutrition. 64(6). 1467–1485. 12 indexed citations
12.
Lü, Yifei, Dengfeng Xu, Yuanyuan Wang, et al.. (2022). Tocotrienol-Rich Fractions Offer Potential to Suppress Pulmonary Fibrosis Progression. International Journal of Molecular Sciences. 23(22). 14331–14331. 5 indexed citations
14.
Lü, Yifei, Yihan Zhang, Dengfeng Xu, et al.. (2022). Long course of low-dose dexamethasone following or after bleomycin administration ameliorates pulmonary fibrosis. International Immunopharmacology. 113(Pt B). 109465–109465. 4 indexed citations
15.
Tang, Olive, Minghao Kou, Yifei Lü, et al.. (2021). Simplified hypertension screening approaches with low misclassification and high efficiency in the United States, Nepal, and India. Journal of Clinical Hypertension. 23(10). 1865–1871. 5 indexed citations
17.
Wei, Jingkai, Yifei Lü, Kun Li, Michael Goodman, & Hanzhang Xu. (2021). The associations of late-life depression with all-cause and cardiovascular mortality: The NHANES 2005–2014. Journal of Affective Disorders. 300. 189–194. 41 indexed citations
18.
Yang, Minjun, Min Zhu, Lijiang Tang, et al.. (2016). Polymorphisms of TGFβ-1 and TGFBR2 in relation to coronary artery disease in a Chinese population. Clinical Biochemistry. 49(12). 873–878. 11 indexed citations
19.
Glusman, J. E., Yifei Lü, William J. Huster, et al.. (1997). P-26.. Menopause The Journal of The North American Menopause Society. 4(4). 260–260. 4 indexed citations
20.
Lü, Yifei, et al.. (1996). Olanzapine in the treatment of schizoaffective disorder. European Neuropsychopharmacology. 6. S4–106. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026